Physician profile
Vivek A Mehta
NPI 1033433776
$442,123.08
in general payments reported to CMS, 2019-2025
34 companies · $101K in 2025
The $101K reported for 2025 was more than what 97% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $13K · 2021: $28K · 2022: $71K · 2023: $113K · 2024: $116K · 2025: $101K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $150K · Food and Beverage: $82K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $60K · Travel and Lodging: $38K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $150,150.00 |
| Food and Beverage | $81,787.13 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $59,920.00 |
| Travel and Lodging | $38,378.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neo Spine USA, INC. | $243,326.93 | 2021-2025 | Neo Pedicle Screw System |
| Medtronic, INC. | $68,329.55 | 2021-2025 | Stealthstation S8 Platform, Stealth Autoguide System, Intellis Adaptivestim |
| Spinevision Sas | $32,901.00 | 2023-2024 | |
| Spineart USA INC | $16,024.59 | 2022-2024 | Perla Tl |
| Microtransponder, INC. | $14,750.00 | 2022-2024 | |
| Nexxt Spine LLC | $11,550.00 | 2024-2025 | Saxxony Navigation, Saxxony Posterior Cervical |
| Medtronic USA, INC. | $11,231.68 | 2019-2020 | |
| Surgical Theater. INC. | $11,200.13 | 2020-2021 | |
| Spinevision INC. | $10,744.75 | 2023 | |
| Carbofix Spine INC | $5,000.00 | 2023 | Carboclear Pedical Screw System |
| Elevation Spine, INC. | $4,500.00 | 2023-2024 | |
| Choice Spine, LLC | $3,825.00 | 2023 | Blackhawk Cervical Spacer System |
| Saluda Medical Americas, INC. | $2,363.33 | 2024-2025 | Evoke |
| Collagen Matrix, INC | $1,500.00 | 2022 | |
| Boston Scientific Corporation | $1,370.13 | 2020-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,267.18 | 2022-2024 | Eterna, Proclaim, Penta |
| Si-Bone, INC. | $435.81 | 2024-2025 | |
| Nevro Corp. | $301.25 | 2020-2024 | Senza |
| Clariance, INC. | $217.28 | 2021-2024 | Erisma-Lp Mis, Idys-C Zp 3dti |
| Nuvasive, INC. | $201.91 | 2022-2023 | Xlif |
| Zap Surgical Systems, INC. | $201.15 | 2023 | Zap-X Mv Imager, Zap-X Treatment Planning Software, Zap-X Treatment Delivery Software |
| Alafair Biosciences, INC. | $151.97 | 2025 | Versawrap |
| Osteomed LLC | $142.78 | 2020 | |
| Biocomposites INC | $142.19 | 2024 | |
| Zimmer Biomet Holdings, INC. | $100.00 | 2019 | |
| Abbvie INC. | $87.12 | 2023-2025 | |
| Globus Medical, INC. | $53.66 | 2025 | Senza |
| Aesculap, INC. | $51.96 | 2025 | Gav |
| Kls-Martin L.P. | $44.29 | 2025 | |
| Seaspine Orthopedics Corporation | $26.65 | 2022 | |
| Sk Life Science, INC. | $24.99 | 2021 | |
| Sanara Medtech INC. | $24.20 | 2024 | Celleraterx |
| Livanova USA, INC. | $16.96 | 2023 | Vns Therapy Symmetry Model 8103 Generator |
| Horizon Therapeutics Plc | $14.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.